Joseph Luminiello

Director Ejecutivo en Third Coast Therapeutics, Inc. .

Health Technology

Commercial Services

Perfil

Joseph Luminiello currently works at Ave Maria Biotechnology LLC, as Chief Executive Officer from 2021 and Third Coast Therapeutics, Inc., as Chief Executive Officer.

Cargos activos de Joseph Luminiello

Empresas	Cargo	Inicio
Third Coast Therapeutics, Inc. Third Coast Therapeutics, Inc. Medical SpecialtiesHealth Technology Third Coast Therapeutics, Inc. engages in pharmaceutical industry. It offers cancer treatment by developing orally active and small molecule drugs. The company is headquartered in Evanston, IL.	Director Ejecutivo	-
Ave Maria Biotechnology LLC Ave Maria Biotechnology LLC Miscellaneous Commercial ServicesCommercial Services Ave Maria Biotechnology LLC provides healthcare services focusing on cell-based therapies. The firm's patented technology utilizes re-programmed adult cells for generic or patient-specific fully human biologic drug manufacturing. The company was founded by Thesesa A. Deisher in 2008 and is headquartered in Seattle, WA.	Director Ejecutivo	01/08/2021

Todos los cargos activos de Joseph Luminiello

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Joseph Luminiello.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	2
Third Coast Therapeutics, Inc. Third Coast Therapeutics, Inc. Medical SpecialtiesHealth Technology Third Coast Therapeutics, Inc. engages in pharmaceutical industry. It offers cancer treatment by developing orally active and small molecule drugs. The company is headquartered in Evanston, IL.	Health Technology
Ave Maria Biotechnology LLC Ave Maria Biotechnology LLC Miscellaneous Commercial ServicesCommercial Services Ave Maria Biotechnology LLC provides healthcare services focusing on cell-based therapies. The firm's patented technology utilizes re-programmed adult cells for generic or patient-specific fully human biologic drug manufacturing. The company was founded by Thesesa A. Deisher in 2008 and is headquartered in Seattle, WA.	Commercial Services